The relationship of a novel drug-resistant phenotype in C3H10T1/2 cells selected with alkylating agents to neoplastic transformation and ATP metabolism

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 195-203

  Wroblewski Giorgio, Diana ^a   Von Hofe, Eric ^a,b  

^a HYBRIDON INC   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alkylating agents; ATP metabolism; Drug resistance; Neoplastic transformation

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; ALKYLATING AGENT; CARMUSTINE; GLUTATHIONE TRANSFERASE; METHYLNITRONITROSOGUANIDINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SELECTION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG RESISTANCE; FIBROBLAST CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CELL SURVIVAL; CELLS, CULTURED; DRUG RESISTANCE; FIBROBLASTS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; METHYLNITRONITROSOGUANIDINE; METHYLTRANSFERASES; MICE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

ANIMALIA; MURINAE;

EID: 0031586762     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04609-0     Document Type: Article

References (48)

1. [1] Berger, N.A. (1986) Cancer chemotherapy: new strategies for success, J. Clin. Invest., 78, 1131-1135.
2. 6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas, Environ. Health Perspect., 62, 119-126.
3. [3] Ferez, R.P., Hamilton, T.C. and Ozols, R.F. (1990) Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems, Pharmacol. Ther., 47, 19-27.
4. [4] Calsou, P. and Salles, B. (1992) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin, Cancer Chemother. Pharmacol., 32, 85-89.
5. [5] Goldmacher, V.S., Cuzick, R.A. and Thilly, W.G. (1986) Isolation and partial characterization of human cell mutant differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine, J. Biol. Chem., 261, 12462-12471.
6. [6] Karran, P. and Bignami, M. (1994) DNA damage tolerance, mismatch repair and genome instability, BioEssays, 16, 833-839.
7. [7] Kiflu, B., Hao, X., Egyhazi, S., Hansson, J., Ringborg, U. and Mannervik, B. (1993) Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line, Cancer Res., 53, 4257-4261.
8. [8] Tew, K.D. (1994) Glutathione-associated enzymes in anticancer drug resistance, Cancer Res., 54, 4313-4320.
9. [9] Morrow, C.S. and Cowan, K.H. (1990) Glutathione S-transferases and drug resistance, Cancer Cells, 2, 15-22.
10. [10] Fornace, A.J. Jr., Alamo, I.J. and Hollander, M.C. (1988) DNA damage-inducible transcripts in mammalian cells, Proc. Natl. Acad. Sci. USA., 85, 8800-8804.
11. [11] Berger, N.A. (1985) Symposium: cellular response to DNA damage; the role of poly(ADP-ribose). Poly(ADP-ribose) in the cellular response to DNA damage, Radiat. Res., 101, 4-15.
12. [12] Berger, N.A., Berger, S.J. and Gerson, S.L. (1987) DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy, Anti-Cancer Drug Design, 2, 203-210.
13. [13] Berger, N.A., Berger, S. and Chatterjee, S. (1993) The roles of Poly(ADP-ribose) polymerase, NAD depletion and essential gene deletion in cancer therapy induced cell death. AACR Special Conference, Death in Cancer and Development (abstract).
14. [14] Marks, D.I. and Fox, R.M. (1991) DNA damage, Poly(ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action, Biochem. Pharmacol., 42 (10), 1859-1867.
15. [15] Cohen, A. and Barankiewicz, J. (1987) Metabolic consequences of DNA damage: alteration in purine metabolism following poly(ADP-ribosyl)ation in human T-lymphoblasts, Arch. Biochem. Biophys., 258, 498-503.
16. [16] Mizumoto, K. and Farber, J.L. (1995) Growth inhibition and cell killing by N-methyl-N-nitrosourea: metabolic alterations that accompany poly(ADP-ribosyl)ation, Arch. Biochem. Biophys., 319, 512-518.
17. 6-alkylguanine-DNA alkyltransferase activity and N-methyl-N′-nitro-N-nitrosoguanidine-induced mutation, transformation and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes, Proc. Natl. Acad. Sci. USA, 89, 11199-11203.
18. [18] Saffhill, R., Margison, G.P. and O'Connor, P.J. (1985) Mechanisms of carcinogenesis induced by alkylating agents, Biochim. Biophys. Acta, 823, 111-145.
19. [19] Brennand, J. and Margison, G.P. (1986) Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene, Proc. Natl. Acad. Sci USA., 83, 6292-6296.
20. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents, Carcinogenesis, 12, 1857-1867.
21. 6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosourea-resistant Chinese hamster ovary cells, Cancer Res., 50, 4248-4253.
22. [22] Reznikoff, C.A., Bertram, J.S., Brankow, D.W. and Heidelberger, C. (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division, Cancer Res., 33, 3239-3249.
23. [23] Nesnow, S., Garland, H. and Curtis, G. (1982) Improved transformation of C3H10T1/2CL8 cells by direct-and indirect-acting carcinogens, Carcinogenesis, 3, 377-380.
24. [24] Landolph, J.R. (1985) Chemical transformation in C3H 10T1/2 C1 8 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol, IARC Sci. Publ., 67, 185-198.
25. 6-alkylguanine-DNA alkyltransferase protects against some of the biological effects of N-methyl-N′-nitro-N-mtro-soguanidine in C3H 10T1/2 cells, Radiat. Res., 127, 220-225.
26. [26] Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J. Biol. Chem., 249 (22), 7130-7139.
27. [27] Akerboom, T.P.M. and Sies, H. (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples, Methods Enzymol., 77, 373-382.
28. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents, Cancer Res., 50, 6119-6129.
29. 6-methylguanine-DNA methyltransferase in mammalian cells by DNA damaging treatments, Mol. Cell. Biol., 11, 4660-4668.
30. [30] Aquilina, G., Zijno, A., Moscufo, N., Dogliotti, E. and Bignami, M. (1989) Tolerance to methylnitrosourea-induced DNA damage is associated with 6-thioguanine resistance in CHO cells, Carcinogenesis, 10, 1219-1223.
31. 6-methylguanine-DNA methyltransferase, Nucleic Acids Res., 11, 7743-7758.
32. [32] Weikam, R.J. and Dolan, M.E. (1989) Intracellular activation of cytotoxic agents: kinetic models for methylnitrosoureas and N′-methyl-N′-nitro-N-nitrosoguanidine in cell culture, Chem. Res. Toxicol., 2, 157-161.
33. 6-methylguanine and methylphosphotriesters to the cytotoxicity of alkylating agents in mammalian cells, Carcinogenesis, 9, 1587-1593.
34. [34] Karran, P. and Williams, S.A. (1985) The cytotoxic and mutagenic effects of alkylating agents on human lymphoid cells are caused by different DNA lesions, Carcinogenesis, 6, 789-792.
35. [35] Kat, A., Thilly, W.G., Fang, W., Longley, M.J., Li, G. and Modrich, P. (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair, Proc. Natl. Acad. Sci. USA, 90, 6424-6428.
36. [36] Ali-Osman, F., Caughlan, J. and Gray, G.S. (1989) Decreased DNA interstrand crosslinking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione, Cancer Res., 49, 5954-5958.
37. [37] Smith, G.J. and Grisham, J.W. (1983) Cytotoxicity of monofunctional alkylating agents. Methyl methanesulfonate and N-methyl-N′-nitro-N-nitrosoguanidine have different mechanisms of toxicity for 10T1/2 cells, Mutat. Res., 111, 405-417.
38. 6-methylguanine in human cell killing, sister chromatid exchange induction and mutagenesis: a review, J. Cell Sci. (SuppL), 6, 333-353.
39. [39] Alvarez-Gonzalez, R. and Althaus, F.R. (1989) Poly(ADP-ribose) catabolism in mammalian cells exposed to DNA-damaging agents, Mutat. Res., 218, 67-74.
40. [40] August, E.M., Cooper, D.L. and Prusoff, W.H. (1991) Inhibition of Poly(adenosine diphosphate-ribose) polymerase by thymidine and thymine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3′-[3-(2-chloroethyl)-3-nitrosoureido]-3′-deoxythymidine. Cancer Res., 51, 1586-1590.
41. [41] Cohen, J.J., Cantino, D.M., Petzold, S.H. and Berger, N.A. (1982) Activation of Poly(adenosine diphosphate ribose) Polymerase by SV 40 minichromosomes: effects of deoxyribonucleic acid damage and histone 1, Biochemistry, 21, 4931-4940.
42. [42] Satoh, M.S., Poirier, G.G. and Lindahl, T. (1994) Dual function for Poly(ADP-ribose) synthesis in response to DNA strand breakage, Biochemistry, 33, 7099-7106.
43. [43] Simms, J.L., Berger, S.J. and Berger, N.A. (1983) Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5′-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis, Biochemistry, 22, 5188-5194.
44. [44] Berger, N.A. (1985) Poly(ADP-ribose) in the cellular response to DNA damage, Radiat. Res., 101, 4-9.
45. [45] Cleaver, J.E., Borek, C., Milam, K. and Morgan, W.F. (1985) The role of poly (ADPribose) synthesis in toxicity and repair of DNA damage, Radiat. Res., 101, 4-15.
46. [46] Baggetto, L.G. (1992) Deviant energetic metabolism of glycolytic cancer cells, Biochimie, 74, 959-974.
47. [47] Golshani, S. (1992) Insulin, growth factors, and cancer cell energy metabolism: an hypothesis on oncogene action, Biochem. Med. Metabol. Biol., 47, 108-115.
48. [48] Fornace, A.J. Jr., Jackman, J., Hollander, M.C., Hoffman-Liebermann, B. and Liebermann, D.A. (1992) Genotoxic-stress-response genes and growth-arrest genes. gadd, MyD, and other genes induced by treatments eliciting growth arrest, Ann. N. Y. Acad. Sci., 663, 139-153.